BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Godinho J, Casa-Nova M, Moreira-Pinto J, Simões P, Paralta Branco F, Leal-Costa L, Faria A, Lopes F, Teixeira JA, Passos-Coelho JL. ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis. Oncologist 2020;25:e284-90. [PMID: 32043787 DOI: 10.1634/theoncologist.2019-0510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Barrau M, Maoui K, Le Roy B, Roblin X, Mismetti P, Phelip JM, Williet N. Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma. J Cancer Res Clin Oncol 2021. [PMID: 33715087 DOI: 10.1007/s00432-021-03590-x] [Reference Citation Analysis]
2 Mosaad M, Elnaem MH, Cheema E, Ibrahim I, Ab Rahman J, Kori AN, Hin HS. Cancer-Associated Thrombosis: A Clinical Scoping Review of the Risk Assessment Models Across Solid Tumours and Haematological Malignancies. Int J Gen Med 2021;14:3881-97. [PMID: 34335052 DOI: 10.2147/IJGM.S320492] [Reference Citation Analysis]
3 Farge D, Bournet B, Conroy T, Vicaut E, Rak J, Zogoulous G, Barkun J, Ouaissi M, Buscail L, Frere C. Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented. Cancers (Basel). 2020;12. [PMID: 32155940 DOI: 10.3390/cancers12030618] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
4 Frere C. Burden of venous thromboembolism in patients with pancreatic cancer. World J Gastroenterol 2021; 27(19): 2325-2340 [PMID: 34040325 DOI: 10.3748/wjg.v27.i19.2325] [Reference Citation Analysis]
5 Candeloro M, Guman NAM, Kraaijpoel N, Di Nisio M. Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients. Semin Thromb Hemost 2021. [PMID: 34111897 DOI: 10.1055/s-0040-1722608] [Reference Citation Analysis]
6 Nicholson M, Chan N, Bhagirath V, Ginsberg J. Prevention of Venous Thromboembolism in 2020 and Beyond. J Clin Med 2020;9:E2467. [PMID: 32752154 DOI: 10.3390/jcm9082467] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
7 Rossel A, Robert-Ebadi H, Marti C. Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review. Cancers (Basel) 2020;12:E612. [PMID: 32155855 DOI: 10.3390/cancers12030612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Valeriani E, Di Nisio M, Riva N, Caiano LM, Porreca E, Bang SM, Beyer-Westendorf J, Sartori MT, Barillari G, Santoro R, Kamphuisen PW, Alatri A, Malato A, Vidili G, Oh D, Schulman S, Ageno W; International Registry on Splanchnic Vein Thrombosis (IRSVT) study group. Clinical history of cancer-associated splanchnic vein thrombosis. J Thromb Haemost 2021;19:983-91. [PMID: 33306241 DOI: 10.1111/jth.15214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Di W, Xu H, Xue T, Ling C. Advances in the Prediction and Risk Assessment of Lung Cancer-Associated Venous Thromboembolism. Cancer Manag Res 2021;13:8317-27. [PMID: 34764694 DOI: 10.2147/CMAR.S328918] [Reference Citation Analysis]
10 Matsumura K, Hayashi H, Uemura N, Zhao L, Higashi T, Yamao T, Kitamura F, Nakao Y, Yusa T, Itoyama R, Imai K, Yamashita YI, Baba H. Prognostic Impact of Coagulation Activity in Patients Undergoing Curative Resection for Pancreatic Ductal Adenocarcinoma. In Vivo 2020;34:2845-50. [PMID: 32871823 DOI: 10.21873/invivo.12111] [Reference Citation Analysis]